During the past decade, Shiga University of Medical Science Hospital conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 16 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 13 clinical trials were completed. i.e. 61.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shiga University of Medical Science Hospital" #1 sponsor was "Shiga University" with 11 trials, followed by "Pfizer" with 6 trials sponsored, "Shire" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shiga University of Medical Science Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Human Genome Center, Institute of Medical Science, University of Tokyo" with 3 trials as a collaborator, "Tokyo University" with 3 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Ako City Hospital" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Shiga University of Medical Science Hospital" are "Ulcerative Colitis" (12 trials), "Crohn's Disease" (7 trials), "Non-small Cell Lung Cancer" (5 trials), "Hypertension" (3 trials) and "ALS" (2 trials). Many other conditions were trialed in "Shiga University of Medical Science Hospital" in a lesser frequency.

Most popular intervention types in "Shiga University of Medical Science Hospital" are "Drug" (44 trials), "Other" (11 trials), "Biological" (7 trials), "Procedure" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Filgotinib" (4 trials) and "Ontamalimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Shiga University of Medical Science Hospital" are 57 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Shiga University of Medical Science Hospital". undefined are not yet recruiting, 6 are recruiting, 15 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in Shiga University of Medical Science Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Shiga University of Medical Science Hospital, 6 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".